Hospital General Universitario de Elche; Servicio de Oncologia
Elche, Alicante, Spain
Cancer treatment center in Elche
Carrer Almazara, 1A, 03203 Elche, Alicante
About Hospital General Universitario de Elche; Servicio de Oncologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
14
Genentech, Inc.
2
Clinical Trials at Hospital General Universitario de Elche; Servicio de Oncologia
During the past decade, Hospital General Universitario de Elche; Servicio de Oncologia conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
2008-10-16
2029-09-20
Recruiting
720
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy
2012-01-11
2022-08-31
Completed
273
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
2013-06-10
2019-12-31
Completed
780
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Universitario de Elche; Servicio de Oncologia"
#1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Hospital General Universitario de Elche; Servicio de Oncologia
According to Clinical.Site data, the most researched conditions in "Hospital General Universitario de Elche; Servicio de Oncologia" are
"Breast Cancer" (5 trials), "Colorectal Cancer" (2 trials), "Carcinoma, Hepatocellular" (1 trials), "Gastric Cancer" (1 trials) and "HER2-Positive Early Breast Cancer" (1 trials). Many other conditions were trialed in "Hospital General Universitario de Elche; Servicio de Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital General Universitario de Elche; Servicio de Oncologia
Most popular intervention types in "Hospital General Universitario de Elche; Servicio de Oncologia" are "Drug" (16 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (7 trials), "Placebo" (6 trials), "Trastuzumab" (5 trials), "Pertuzumab" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital General Universitario de Elche; Servicio de Oncologia
The vast majority of trials in "Hospital General Universitario de Elche; Servicio de Oncologia" are
15 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Hospital General Universitario de Elche; Servicio de Oncologia
Currently, there are NaN active trials in "Hospital General Universitario de Elche; Servicio de Oncologia".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Hospital General Universitario de Elche; Servicio de Oncologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital General Universitario de Elche; Servicio de Oncologia, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".